XML 112 R94.htm IDEA: XBRL DOCUMENT v3.5.0.2
Information as to Operating Segments and Foreign and Domestic Operations - Concentration Risk (Details)
3 Months Ended 12 Months Ended
Jul. 31, 2016
USD ($)
Apr. 30, 2016
USD ($)
Jan. 31, 2016
USD ($)
Oct. 31, 2015
USD ($)
Jul. 31, 2015
USD ($)
Apr. 30, 2015
USD ($)
Jan. 31, 2015
USD ($)
Oct. 31, 2014
USD ($)
Jul. 31, 2016
USD ($)
item
Jul. 31, 2015
USD ($)
Jul. 31, 2014
USD ($)
Concentration risk                      
Consolidated net sales $ 179,002,000 $ 173,703,000 $ 158,271,000 $ 153,779,000 $ 151,255,000 $ 141,508,000 $ 135,430,000 $ 136,811,000 $ 664,755,000 $ 565,004,000 $ 488,749,000
Water Purification and Filtration                      
Concentration risk                      
Consolidated net sales                 177,669,000 173,834,000 159,505,000
Healthcare Disposables                      
Concentration risk                      
Consolidated net sales                 112,584,000 106,920,000 101,809,000
Dialysis                      
Concentration risk                      
Consolidated net sales                 $ 32,750,000 $ 31,240,000 $ 30,926,000
Customer concentration | Segment sales | Water Purification and Filtration | Two customers                      
Concentration risk                      
Number of customers accounting for a percentage of segment net sales | item                 2    
Concentration risk within segment (as a percent)                 43.70%    
Customer concentration | Segment sales | Healthcare Disposables | Four customers                      
Concentration risk                      
Number of customers accounting for a percentage of segment net sales | item                 4    
Concentration risk within segment (as a percent)                 49.10%    
Customer concentration | Segment sales | Dialysis | Fresenius and DaVita                      
Concentration risk                      
Concentration risk within segment (as a percent)                 42.60%    
Customer concentration | Net sales | Da Vita Inc                      
Concentration risk                      
Concentration risk within segment (as a percent)                     10.00%
Consolidated net sales                     $ 48,620,000